Abstract
Despite a number of beneficent outcomes, clinical trials on human subjects have exposed some of the worst forms of state crime, most notably in Nazi Germany. Even with the subsequent establishment of guidelines for the protection of human subjects, such as the Nuremberg Code, clinical trials resulting in death and injury is a continuing feature of medical research, especially as Western states outsource more trials to the private sector where profit margins often trump personal safety. Focusing on the clinical trials business in India, the article argues that the exploitation of human subjects in developing countries, affecting as it does the most vulnerable groups, must be understood as a form of state-corporate crime. In this way, the moral distance we prefer to place between Nazi medical crimes and those committed in the interests of neoliberal values becomes less viable and the need for effective responses to unethical clinical trials more pressing.
No comments:
Post a Comment